Parin J Patel1, Yuliya Borovskiy2, Anthony Killian2, Ralph J Verdino2, Andrew E Epstein2, David J Callans2, Francis E Marchlinski2, Rajat Deo2. 1. St. Vincent Medical Group, Division of Cardiology, Indianapolis, Indiana; Section of Electrophysiology, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: parin.patel@post.harvard.edu. 2. Section of Electrophysiology, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: The QT interval measures cardiac repolarization, and prolongation is associated with adverse cardiovascular outcomes and death. The exponential Bazett correction formula overestimates the QT interval during tachycardia. OBJECTIVE: We evaluated 4 formulas of QT interval correction in individuals with sinus tachycardia for the identification of coronary artery disease, heart failure, and mortality. METHODS: The Penn Atrial Fibrillation Free study is a large cohort study of patients without atrial fibrillation. The present study examined 6723 Penn Atrial Fibrillation Free study patients without a history of heart failure and with baseline sinus rate ≥100 beats/min. Medical records were queried for index clinical parameters, incident cardiovascular events, and all-cause mortality. The QT interval was corrected by using Bazett (QT/RR(0.5)), Fridericia (QT/RR(0.33)), Framingham [QT + 0.154 * (1000 - RR)], and Hodges (QT + 105 * (1/RR - 1)) formulas. RESULTS: In 6723 patients with a median follow-up of 4.5 years (interquartile range 1.9-6.4 years), the annualized cardiovascular event rate was 2.3% and the annualized mortality rate was 2.2%. QT prolongation was diagnosed in 39% of the cohort using the Bazett formula, 6.2% using the Fridericia formula, 3.7% using the Framingham formula, and 8.7% using the Hodges formula. Only the Hodges formula was an independent risk marker for death across the range of QT values (highest tertile: hazard ratio 1.26; 95% confidence interval 1.03-1.55). CONCLUSION: Although all correction formulas demonstrated an association between QTc values and cardiovascular events, only the Hodges formula identified one-third of individuals with tachycardia that are at higher risk of all-cause mortality. Furthermore, the Bazett correction formula overestimates the number of patients with a prolonged QT interval and was not associated with mortality. Future work may validate these findings and result in changes to automated algorithms for QT interval assessment.
BACKGROUND: The QT interval measures cardiac repolarization, and prolongation is associated with adverse cardiovascular outcomes and death. The exponential Bazett correction formula overestimates the QT interval during tachycardia. OBJECTIVE: We evaluated 4 formulas of QT interval correction in individuals with sinus tachycardia for the identification of coronary artery disease, heart failure, and mortality. METHODS: The Penn Atrial Fibrillation Free study is a large cohort study of patients without atrial fibrillation. The present study examined 6723 Penn Atrial Fibrillation Free study patients without a history of heart failure and with baseline sinus rate ≥100 beats/min. Medical records were queried for index clinical parameters, incident cardiovascular events, and all-cause mortality. The QT interval was corrected by using Bazett (QT/RR(0.5)), Fridericia (QT/RR(0.33)), Framingham [QT + 0.154 * (1000 - RR)], and Hodges (QT + 105 * (1/RR - 1)) formulas. RESULTS: In 6723 patients with a median follow-up of 4.5 years (interquartile range 1.9-6.4 years), the annualized cardiovascular event rate was 2.3% and the annualized mortality rate was 2.2%. QT prolongation was diagnosed in 39% of the cohort using the Bazett formula, 6.2% using the Fridericia formula, 3.7% using the Framingham formula, and 8.7% using the Hodges formula. Only the Hodges formula was an independent risk marker for death across the range of QT values (highest tertile: hazard ratio 1.26; 95% confidence interval 1.03-1.55). CONCLUSION: Although all correction formulas demonstrated an association between QTc values and cardiovascular events, only the Hodges formula identified one-third of individuals with tachycardia that are at higher risk of all-cause mortality. Furthermore, the Bazett correction formula overestimates the number of patients with a prolonged QT interval and was not associated with mortality. Future work may validate these findings and result in changes to automated algorithms for QT interval assessment.
Authors: Pentti M Rautaharju; Borys Surawicz; Leonard S Gettes; James J Bailey; Rory Childers; Barbara J Deal; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Gerard van Herpen; Galen S Wagner; Hein Wellens Journal: J Am Coll Cardiol Date: 2009-03-17 Impact factor: 24.094
Authors: Anders Opdahl; Bharath Ambale Venkatesh; Veronica R S Fernandes; Colin O Wu; Khurram Nasir; Eui-Young Choi; Andre L C Almeida; Boaz Rosen; Benilton Carvalho; Thor Edvardsen; David A Bluemke; João A C Lima Journal: J Am Coll Cardiol Date: 2014-01-08 Impact factor: 24.094
Authors: Bojan Vrtovec; Reynolds Delgado; Aly Zewail; Cynthia D Thomas; Barbara M Richartz; Branislav Radovancevic Journal: Circulation Date: 2003-03-24 Impact factor: 29.690
Authors: M Zabel; M R Franz; T Klingenheben; B Mansion; H P Schultheiss; S H Hohnloser Journal: J Am Coll Cardiol Date: 2000-11-01 Impact factor: 24.094
Authors: Andrew J Sauer; Arthur J Moss; Scott McNitt; Derick R Peterson; Wojciech Zareba; Jennifer L Robinson; Ming Qi; Ilan Goldenberg; Jenny B Hobbs; Michael J Ackerman; Jesaia Benhorin; W Jackson Hall; Elizabeth S Kaufman; Emanuela H Locati; Carlo Napolitano; Silvia G Priori; Peter J Schwartz; Jeffrey A Towbin; G Michael Vincent; Li Zhang Journal: J Am Coll Cardiol Date: 2007-01-04 Impact factor: 24.094
Authors: David D Kim; Randall F White; Alasdair M Barr; William G Honer; Ric M Procyshyn Journal: J Psychiatry Neurosci Date: 2018-01 Impact factor: 6.186
Authors: Parin J Patel; Ronit Katz; Yuliya Borovskiy; Anthony Killian; Joshua M Levine; Nelson W McNaughton; David Callans; Gregory Supple; Sanjay Dixit; Andrew E Epstein; Francis E Marchlinski; Rajat Deo Journal: Heart Rhythm Date: 2018-02-20 Impact factor: 6.343
Authors: Esther D Kim; Jacqueline Watt; Larisa G Tereshchenko; Bernard G Jaar; Stephen M Sozio; W H Linda Kao; Michelle M Estrella; Rulan S Parekh Journal: BMC Nephrol Date: 2019-04-18 Impact factor: 2.388
Authors: Rebecca E Greenblatt; Edward J Zhao; Sarah E Henrickson; Andrea J Apter; Rebecca A Hubbard; Blanca E Himes Journal: Asthma Res Pract Date: 2019-01-18
Authors: Santiago Colunga; Remigio Padrón; Daniel García-Iglesias; José Manuel Rubín; Diego Pérez; Raquel Del Valle; Pablo Avanzas; César Morís; David Calvo Journal: J Clin Med Date: 2019-09-09 Impact factor: 4.241